Source:http://linkedlifedata.com/resource/pubmed/id/18675814
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
20
|
pubmed:dateCreated |
2008-8-25
|
pubmed:abstractText |
Knowledge of the regulatory factors associated with down-regulation of adiponectin gene expression and up-regulation of PAI-1 gene expression is crucial to understand the pathophysiological basis of obesity and metabolic diseases, and could establish new treatment strategies for these conditions. We showed that expression of 5-HT(2A) receptors was up-regulated in hypertrophic 3T3-L1 adipocytes, which exhibited decreased expression of adiponectin and increased expression of PAI-1. 5-HT(2A) receptor antagonists and suppression of 5-HT(2A) receptor gene expression enhanced adiponectin expression. Activation of Gq negatively regulated adiponectin expression, and inhibition of mitogen-activated protein kinase reversed the Gq-induced effect. Moreover, the 5-HT(2A) receptor blockade reduced PAI-1 expression. These findings indicate that antagonism of 5-HT(2A) receptors in adipocytes could improve the obesity-linked decreases in adiponectin expression and increases in PAI-1 expression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adiponectin,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2A,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin 5-HT2 Receptor Antagonists
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0014-5793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
582
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3037-44
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:18675814-3T3-L1 Cells,
pubmed-meshheading:18675814-Adipocytes,
pubmed-meshheading:18675814-Adipogenesis,
pubmed-meshheading:18675814-Adiponectin,
pubmed-meshheading:18675814-Adipose Tissue,
pubmed-meshheading:18675814-Animals,
pubmed-meshheading:18675814-Gene Expression,
pubmed-meshheading:18675814-Male,
pubmed-meshheading:18675814-Mice,
pubmed-meshheading:18675814-Mice, Inbred C57BL,
pubmed-meshheading:18675814-Obesity,
pubmed-meshheading:18675814-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:18675814-Receptor, Serotonin, 5-HT2A,
pubmed-meshheading:18675814-Serotonin 5-HT2 Receptor Antagonists,
pubmed-meshheading:18675814-Signal Transduction
|
pubmed:year |
2008
|
pubmed:articleTitle |
5-Hydroxytryptamine 2A receptor signaling cascade modulates adiponectin and plasminogen activator inhibitor 1 expression in adipose tissue.
|
pubmed:affiliation |
Pharmacology Department II, Mitsubishi Tanabe Pharma Corporation, Toda-shi, Saitama 335-8505, Japan.
|
pubmed:publicationType |
Journal Article
|